7-100057800-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145914.3(ZSCAN21):c.502A>G(p.Thr168Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145914.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZSCAN21 | ENST00000292450.9 | c.502A>G | p.Thr168Ala | missense_variant | Exon 3 of 4 | 1 | NM_145914.3 | ENSP00000292450.4 | ||
ZSCAN21 | ENST00000456748.6 | c.502A>G | p.Thr168Ala | missense_variant | Exon 3 of 5 | 5 | ENSP00000390960.2 | |||
ZSCAN21 | ENST00000438937.1 | c.502A>G | p.Thr168Ala | missense_variant | Exon 4 of 4 | 2 | ENSP00000404207.1 | |||
ZSCAN21 | ENST00000477297.1 | n.598A>G | non_coding_transcript_exon_variant | Exon 2 of 3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251312 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727220 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.502A>G (p.T168A) alteration is located in exon 3 (coding exon 2) of the ZSCAN21 gene. This alteration results from a A to G substitution at nucleotide position 502, causing the threonine (T) at amino acid position 168 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at